Standout Papers
Immediate Impact
8 by Nobel laureates 24 from Science/Nature 58 standout
Citing Papers
Targeted protein degradation: from mechanisms to clinic
2024 Standout
Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
2023 Standout
Works of Marc S. Raab being referenced
A Phase 1 First in Human (FIH) Study of AMG 701, an Anti-B-Cell Maturation Antigen (BCMA) Half-Life Extended (HLE) BiTE® (bispecific T-cell engager) Molecule, in Relapsed/Refractory (RR) Multiple Myeloma (MM)
2020
Elotuzumab plus Pomalidomide and Dexamethasone for Multiple Myeloma
2018 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Marc S. Raab | 3452 | 3286 | 2368 | 199 | 5.3k | |
| Peter M. Voorhees | 2816 | 3201 | 2660 | 170 | 5.1k | |
| Suzanne Trudel | 2952 | 3341 | 2243 | 243 | 5.1k | |
| Jacob P. Laubach | 3845 | 3817 | 2622 | 229 | 5.9k | |
| Suzanne Lentzsch | 4709 | 4297 | 3252 | 219 | 6.9k | |
| Andrzej Jakubowiak | 3991 | 4056 | 2988 | 257 | 6.1k | |
| Jérôme Moreaux | 1924 | 2862 | 1442 | 167 | 4.7k | |
| Jonathan L. Kaufman | 5075 | 4854 | 3507 | 318 | 7.7k | |
| Nizar J. Bahlis | 4063 | 3652 | 2693 | 348 | 5.7k | |
| Stéphane Minvielle | 2681 | 3113 | 1600 | 146 | 4.4k | |
| Karin Vanderkerken | 3525 | 4399 | 3108 | 224 | 7.7k |
All Works
Login with ORCID to disown or claim papers
Loading papers...